greeksoup/ stock research
Stock research / United States / BNTX / Year to 31 December 2021

BioNTech SE (BNTX) annual results, year to 31 December 2021: revenue EUR 18,977 million, from the 20-F

BioNTech SE files a 20-F with the SEC once a year, in euros. In the year to 31 December 2021 it reported revenue of EUR 18,977 million ($22.5 billion at the year's average rate), up 3834.6% on the year before. Its profit attributable to shareholders was EUR 10,292 million, up 67613.8%, and diluted earnings per share EUR 39.63.

Revenue
EUR 18,977 million
+3,834.6% on the year
FY2017FY2021
Operating margin
80.5%
-17.1% a year earlier
FY2017FY2021
Net income
EUR 10,292 million
+67,613.8% on the year
FY2017FY2021
Diluted EPS
EUR 39.63
+65,950.0% on the year
FY2017FY2021

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2020 †Dec 2021 †
Revenue48218,977
Cost of sales59.32,912
Research and development645949
Operating profit-82.415,284
Finance costs65.0305
Profit before tax-14615,046
Income tax-1614,754
Profit for the year15.210,292
Profit attributable to shareholders15.210,292
Filing20-F20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2020 †Dec 2021 †
Diluted EPS0.0639.63
Basic EPS0.0642.18
Filing20-F20-F

EUR per ordinary share, as filed.

Cash flow

Year toDec 2020 †Dec 2021 †
Cash from operations-13.5890
Purchase of property, plant and equipment66.0128
Free cash flow-79.5762
Cash from investing-145-566
Cash from financing89594.2
Depreciation and amortisation38.775.2
Dividends paid0.00.0
Filing20-F20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2020 †Dec 2021 †
Funded by
Equity attributable to shareholders1,37211,894
Borrowings, as filed240302
Lease liabilities84.2182
Other liabilities6223,454
Total equity and liabilities2,31915,831
Owned
Property, plant and equipment227322
Goodwill53.757.8
Cash and cash equivalents1,2101,693
Trade and other receivables16612,382
Inventories64.1502
Other assets598874
Total assets2,31915,831
Filing20-F20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2020 †Dec 2021 †
Operating margin-17.1%80.5%
Net margin3.2%54.2%
Free cash flow margin-16.5%4.0%
Return on year-end equity1.1%86.5%
Effective tax raten/a31.6%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2021, filed 20 March 2024: the filing. The figures are in euros as filed.